ALK and colorectal cancer: Bavi et al. reported that ALK gene amplification was associated with poor prognosis in colorectal cancer using fluorescence in situ hybridisation (FISH) and immunohistochemistry as a screening tool to detect the prevalence of ALK copy number changes, translocations, gene mutations and protein expression 21.